Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	8,118	7,320	13,192	10,163	-	-
Market Cap Growth	-37.59%	-44.51%	29.81%	-	-	-
Enterprise Value	8,207	7,469	13,164	10,212	-	-
Last Close Price	696.35	627.90	1118.05	860.48	-	-
PE Ratio	17.77	19.79	45.38	49.53	-	-
PS Ratio	0.95	0.86	2.13	4.77	-	-
PB Ratio	2.09	1.89	4.67	5.80	-	-
P/TBV Ratio	2.37	2.14	5.34	6.83	-	-
P/FCF Ratio	226.13	203.90	439.73	-	-	-
P/OCF Ratio	44.70	40.31	189.00	752.80	-	-
EV/Sales Ratio	0.96	0.88	2.12	4.80	-	-
EV/EBITDA Ratio	14.48	13.18	29.25	35.56	-	-
EV/EBIT Ratio	15.22	13.85	30.04	36.68	-	-
EV/FCF Ratio	228.61	208.04	438.80	-	-	-
Debt / Equity Ratio	0.07	0.07	0.08	0.08	0.42	0.03
Debt / EBITDA Ratio	0.48	0.48	0.50	0.49	0.71	0.04
Debt / FCF Ratio	7.54	7.54	7.66	-	3.08	0.04
Net Debt / Equity Ratio	-0.07	-0.07	-0.01	-0.06	0.26	-0.14
Net Debt / EBITDA Ratio	-0.49	-0.49	-0.09	-0.37	0.44	-0.22
Net Debt / FCF Ratio	-7.75	-7.75	-1.43	5.53	1.90	-0.19
Asset Turnover	1.69	1.69	1.62	1.16	1.79	1.84
Inventory Turnover	12.01	12.01	11.26	7.53	22.88	8.96
Quick Ratio	1.31	1.31	1.11	0.99	0.97	0.44
Current Ratio	1.98	1.98	1.82	1.51	1.39	0.84
Return on Equity (ROE)	13.78%	13.78%	16.79%	24.98%	66.14%	71.37%
Return on Assets (ROA)	6.67%	6.67%	7.15%	9.46%	26.40%	19.63%
Return on Invested Capital (ROIC)	11.70%	13.19%	16.06%	23.77%	53.60%	77.53%
Return on Capital Employed (ROCE)	12.60%	12.60%	14.10%	14.50%	40.30%	63.30%
Earnings Yield	4.56%	5.05%	2.20%	2.02%	-	-
FCF Yield	0.44%	0.49%	0.23%	-0.19%	-	-
Dividend Yield	0.14%	0.16%	0.07%	0.09%	-	-
Payout Ratio	3.19%	3.19%	4.06%	2.88%	-	-
Buyback Yield / Dilution	19.90%	19.90%	-4.28%	-38.35%	-2.10%	-
Total Shareholder Return	20.05%	20.06%	-4.21%	-38.27%	-2.10%	-